null

SMILES: CCC(CC)n1cc(cn1)-c1nc(cn2nccc12)-c1cnn(C[C@H](CN)OC)c1

InChI Key: InChIKey=OIAGAWSCJMASIN-SFHVURJKSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 12 hits for monomerid = 325487   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Non-receptor tyrosine-protein kinase TYK2 (Homo sapiens (Human))	BDBM325487 (US10189845, Example 149B | US10730880, Example 149...) Show SMILES CCC(CC)n1cc(cn1)-c1nc(cn2nccc12)-c1cnn(C[C@H](CN)OC)c1 |r| Show InChI InChI=1S/C21H28N8O/c1-4-17(5-2)28-12-16(10-25-28)21-20-6-7-23-29(20)14-19(26-21)15-9-24-27(11-15)13-18(8-22)30-3/h6-7,9-12,14,17-18H,4-5,8,13,22H2,1-3H3/t18-/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	55	n/a	n/a	n/a	n/a	n/a	n/a
Array BioPharma Inc. US Patent					Assay Description Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture c...				US Patent US10189845 (2019) BindingDB Entry DOI: 10.7270/Q2Z03B7Q
					More data for this Ligand-Target Pair
Tyrosine-protein kinase JAK1 (Homo sapiens (Human))	BDBM325487 (US10189845, Example 149B | US10730880, Example 149...) Show SMILES CCC(CC)n1cc(cn1)-c1nc(cn2nccc12)-c1cnn(C[C@H](CN)OC)c1 |r| Show InChI InChI=1S/C21H28N8O/c1-4-17(5-2)28-12-16(10-25-28)21-20-6-7-23-29(20)14-19(26-21)15-9-24-27(11-15)13-18(8-22)30-3/h6-7,9-12,14,17-18H,4-5,8,13,22H2,1-3H3/t18-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5.50E+3	n/a	n/a	n/a	n/a	n/a	n/a
Array BioPharma Inc. US Patent					Assay Description Compounds of Formula I were screened for their ability to inhibit JAK1 using the general enzyme inhibition assay method, in which the assay mixture c...				US Patent US10189845 (2019) BindingDB Entry DOI: 10.7270/Q2Z03B7Q
					More data for this Ligand-Target Pair
Tyrosine-protein kinase JAK2 (Homo sapiens (Human))	BDBM325487 (US10189845, Example 149B | US10730880, Example 149...) Show SMILES CCC(CC)n1cc(cn1)-c1nc(cn2nccc12)-c1cnn(C[C@H](CN)OC)c1 |r| Show InChI InChI=1S/C21H28N8O/c1-4-17(5-2)28-12-16(10-25-28)21-20-6-7-23-29(20)14-19(26-21)15-9-24-27(11-15)13-18(8-22)30-3/h6-7,9-12,14,17-18H,4-5,8,13,22H2,1-3H3/t18-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	55	n/a	n/a	n/a	n/a	n/a	n/a
Array BioPharma Inc. US Patent					Assay Description Compounds of Formula I were screened for their ability to inhibit JAK2 using the general enzyme inhibition assay method, in which the assay mixture c...				US Patent US10189845 (2019) BindingDB Entry DOI: 10.7270/Q2Z03B7Q
					More data for this Ligand-Target Pair
Tyrosine-protein kinase JAK3 (Homo sapiens (Human))	BDBM325487 (US10189845, Example 149B | US10730880, Example 149...) Show SMILES CCC(CC)n1cc(cn1)-c1nc(cn2nccc12)-c1cnn(C[C@H](CN)OC)c1 |r| Show InChI InChI=1S/C21H28N8O/c1-4-17(5-2)28-12-16(10-25-28)21-20-6-7-23-29(20)14-19(26-21)15-9-24-27(11-15)13-18(8-22)30-3/h6-7,9-12,14,17-18H,4-5,8,13,22H2,1-3H3/t18-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5.50E+3	n/a	n/a	n/a	n/a	n/a	n/a
Array BioPharma Inc. US Patent					Assay Description Compounds of Formula I were screened for their ability to inhibit JAK3 using the general enzyme inhibition assay method, in which the assay mixture c...				US Patent US10189845 (2019) BindingDB Entry DOI: 10.7270/Q2Z03B7Q
					More data for this Ligand-Target Pair
Non-receptor tyrosine-protein kinase TYK2 (Homo sapiens (Human))	BDBM325487 (US10189845, Example 149B | US10730880, Example 149...) Show SMILES CCC(CC)n1cc(cn1)-c1nc(cn2nccc12)-c1cnn(C[C@H](CN)OC)c1 |r| Show InChI InChI=1S/C21H28N8O/c1-4-17(5-2)28-12-16(10-25-28)21-20-6-7-23-29(20)14-19(26-21)15-9-24-27(11-15)13-18(8-22)30-3/h6-7,9-12,14,17-18H,4-5,8,13,22H2,1-3H3/t18-/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	55	n/a	n/a	n/a	n/a	n/a	n/a
Array BioPharma Inc.; Celgene Corporation US Patent					Assay Description Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture c...				US Patent US10730880 (2020)
					More data for this Ligand-Target Pair
Tyrosine-protein kinase JAK3 (Homo sapiens (Human))	BDBM325487 (US10189845, Example 149B | US10730880, Example 149...) Show SMILES CCC(CC)n1cc(cn1)-c1nc(cn2nccc12)-c1cnn(C[C@H](CN)OC)c1 |r| Show InChI InChI=1S/C21H28N8O/c1-4-17(5-2)28-12-16(10-25-28)21-20-6-7-23-29(20)14-19(26-21)15-9-24-27(11-15)13-18(8-22)30-3/h6-7,9-12,14,17-18H,4-5,8,13,22H2,1-3H3/t18-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5.50E+3	n/a	n/a	n/a	n/a	n/a	n/a
ARRAY BIOPHARMA INC.; CELGENE CORPORATION US Patent					Assay Description Compounds of Formula I were screened for their ability to inhibit JAK3 using the general enzyme inhibition assay method, in which the assay mixture c...				US Patent US11028093 (2021)
					More data for this Ligand-Target Pair
Tyrosine-protein kinase JAK2 (Homo sapiens (Human))	BDBM325487 (US10189845, Example 149B | US10730880, Example 149...) Show SMILES CCC(CC)n1cc(cn1)-c1nc(cn2nccc12)-c1cnn(C[C@H](CN)OC)c1 |r| Show InChI InChI=1S/C21H28N8O/c1-4-17(5-2)28-12-16(10-25-28)21-20-6-7-23-29(20)14-19(26-21)15-9-24-27(11-15)13-18(8-22)30-3/h6-7,9-12,14,17-18H,4-5,8,13,22H2,1-3H3/t18-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	55	n/a	n/a	n/a	n/a	n/a	n/a
Array BioPharma Inc.; Celgene Corporation US Patent					Assay Description Compounds of Formula I were screened for their ability to inhibit JAK2 using the general enzyme inhibition assay method, in which the assay mixture c...				US Patent US10730880 (2020)
					More data for this Ligand-Target Pair
Tyrosine-protein kinase JAK3 (Homo sapiens (Human))	BDBM325487 (US10189845, Example 149B | US10730880, Example 149...) Show SMILES CCC(CC)n1cc(cn1)-c1nc(cn2nccc12)-c1cnn(C[C@H](CN)OC)c1 |r| Show InChI InChI=1S/C21H28N8O/c1-4-17(5-2)28-12-16(10-25-28)21-20-6-7-23-29(20)14-19(26-21)15-9-24-27(11-15)13-18(8-22)30-3/h6-7,9-12,14,17-18H,4-5,8,13,22H2,1-3H3/t18-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5.50E+3	n/a	n/a	n/a	n/a	n/a	n/a
Array BioPharma Inc.; Celgene Corporation US Patent					Assay Description Compounds of Formula I were screened for their ability to inhibit JAK3 using the general enzyme inhibition assay method, in which the assay mixture c...				US Patent US10730880 (2020)
					More data for this Ligand-Target Pair
Non-receptor tyrosine-protein kinase TYK2 (Homo sapiens (Human))	BDBM325487 (US10189845, Example 149B | US10730880, Example 149...) Show SMILES CCC(CC)n1cc(cn1)-c1nc(cn2nccc12)-c1cnn(C[C@H](CN)OC)c1 |r| Show InChI InChI=1S/C21H28N8O/c1-4-17(5-2)28-12-16(10-25-28)21-20-6-7-23-29(20)14-19(26-21)15-9-24-27(11-15)13-18(8-22)30-3/h6-7,9-12,14,17-18H,4-5,8,13,22H2,1-3H3/t18-/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	55	n/a	n/a	n/a	n/a	n/a	n/a
ARRAY BIOPHARMA INC.; CELGENE CORPORATION US Patent					Assay Description Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture c...				US Patent US11028093 (2021)
					More data for this Ligand-Target Pair
Tyrosine-protein kinase JAK1 (Homo sapiens (Human))	BDBM325487 (US10189845, Example 149B | US10730880, Example 149...) Show SMILES CCC(CC)n1cc(cn1)-c1nc(cn2nccc12)-c1cnn(C[C@H](CN)OC)c1 |r| Show InChI InChI=1S/C21H28N8O/c1-4-17(5-2)28-12-16(10-25-28)21-20-6-7-23-29(20)14-19(26-21)15-9-24-27(11-15)13-18(8-22)30-3/h6-7,9-12,14,17-18H,4-5,8,13,22H2,1-3H3/t18-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5.50E+3	n/a	n/a	n/a	n/a	n/a	n/a
ARRAY BIOPHARMA INC.; CELGENE CORPORATION US Patent					Assay Description Compounds of Formula I were screened for their ability to inhibit JAK1 using the general enzyme inhibition assay method, in which the assay mixture c...				US Patent US11028093 (2021)
					More data for this Ligand-Target Pair
Tyrosine-protein kinase JAK2 (Homo sapiens (Human))	BDBM325487 (US10189845, Example 149B | US10730880, Example 149...) Show SMILES CCC(CC)n1cc(cn1)-c1nc(cn2nccc12)-c1cnn(C[C@H](CN)OC)c1 |r| Show InChI InChI=1S/C21H28N8O/c1-4-17(5-2)28-12-16(10-25-28)21-20-6-7-23-29(20)14-19(26-21)15-9-24-27(11-15)13-18(8-22)30-3/h6-7,9-12,14,17-18H,4-5,8,13,22H2,1-3H3/t18-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	55	n/a	n/a	n/a	n/a	n/a	n/a
ARRAY BIOPHARMA INC.; CELGENE CORPORATION US Patent					Assay Description Compounds of Formula I were screened for their ability to inhibit JAK2 using the general enzyme inhibition assay method, in which the assay mixture c...				US Patent US11028093 (2021)
					More data for this Ligand-Target Pair
Tyrosine-protein kinase JAK1 (Homo sapiens (Human))	BDBM325487 (US10189845, Example 149B | US10730880, Example 149...) Show SMILES CCC(CC)n1cc(cn1)-c1nc(cn2nccc12)-c1cnn(C[C@H](CN)OC)c1 |r| Show InChI InChI=1S/C21H28N8O/c1-4-17(5-2)28-12-16(10-25-28)21-20-6-7-23-29(20)14-19(26-21)15-9-24-27(11-15)13-18(8-22)30-3/h6-7,9-12,14,17-18H,4-5,8,13,22H2,1-3H3/t18-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5.50E+3	n/a	n/a	n/a	n/a	n/a	n/a
Array BioPharma Inc.; Celgene Corporation US Patent					Assay Description Compounds of Formula I were screened for their ability to inhibit JAK1 using the general enzyme inhibition assay method, in which the assay mixture c...				US Patent US10730880 (2020)
					More data for this Ligand-Target Pair